Essays on Biopharmaceuticals

Status of the document.

This document is a project proposal for the development of starch-based hemostatic products. Acknowledgement. Much thanks to the project supervisor who offered guidance in every step of the development of this proposal. Developing starch based hemostatic products Project summary. Purpose: This proposal is envisioned to develop a hemostatic agent from purified plant starch. In this case, the product of the reaction should be developed by the formation of microporous hemosphere particles after etherification, esterification and crosslinking of glucose molecules to form ethyl propanetriol (glycerol-ether links (1-3 deoxy propanol)). The second intention of this study is to investigate the properties ...

Commercializing Biotechnology in Early-Stage Ventures.

Introduction: Ajinomoto Althea, Inc. is a drug manufacturing and contract development organization that provides clinical drug manufacturing and process development services to various global pharmaceutical and biotechnology firms. The company claims to be capable of fully supporting early stages clinical requirements via commercial manufacturing.

History and Background Information:

Althea Inc. was founded in 1998 by Francois Ferre, Ph.D. and Magda Marquet, Ph.D. and its first products were gene quantification assays and plasmids kits. The company delved into manufacturing microbial biologics in 2000, and by 2003, the company was now offering finish and fill manufacturing services to meet client demands. In 2008, due to ...

Cancer Treatment Worldwide

Cancer industry and Big Pharma's effect on treatment and drugs in the United States of America is different from that of other countries’ largely because of its interaction with the United States Food and Drug Administration (FDA) . The United States’ Patent Office also has its share in the problem. Pharmaceutical companies do not want to fund research into a drug that will not pass through the FDA usage guidelines if it will be off patent before it can be sold for cancer treatment , , . A new law, signed in July 2012 will change how the industry views this. While patent ...